Title 21, Food and DrugsRelease 119-110

§1704 Coordination with National Drug Control Program Agencies in Demand Reduction, Supply Reduction, and State and Local Affairs

Title 21 › CHAPTER 22 — NATIONAL DRUG CONTROL POLICY › § 1704

Last updated Sep 22, 2026|Official source

Summary

Federal drug-control agencies must give the Director any statistics, studies, reports, or other information about drug control or how drug-control money is spent when the Director asks. Information that could reveal intelligence sources or methods must be handled under the National Security Act of 1947, and the Director of National Intelligence will write rules to protect it. The Director of National Intelligence and the CIA must help the Office as much as they reasonably can. Each year the Secretaries of Agriculture and the Interior must send a joint report by July 1 about illegal drug growing on federal lands. The Secretary of Homeland Security and the Secretary of Defense must each send, by July 1, yearly reports about drug seizures and air and maritime patrol hours for drug missions. The Attorney General must send, by July 1, yearly counts of arrests, prosecutions, and seizures and where they happened. Heads of drug-control agencies must tell the Director in writing before changing drug-control policies, unless an emergency prevents it; the Director will quickly review and say if the change fits the national strategy. The General Services Administration must give reimbursable support services if asked. Agencies must send a detailed, Inspector General–authenticated accounting of drug-control spending by February 1 each year; the Director sends that to Congress by April 1. The Director may award grants to nonprofits to train drug courts, with $2,000,000 authorized for each year 2018–2023. The Director, with HHS, must build a public electronic system to list all federal drug-control grants, results, and gaps; agencies must give and update their grant lists yearly. The Comptroller General must report to Congress on this system within 3 years after October 24, 2018.

Full Legal Text

Title 21, §1704

Food and Drugs, Source: USLM XML via OLRC

(a)Access to information
(1)In general
Upon the request of the Director, the head of any National Drug Control Program agency shall cooperate with and provide to the Director any statistics, studies, reports, and other information prepared or collected by the agency concerning the responsibilities of the agency under the National Drug Control Strategy that relate to—
(A)drug control; or
(B)the manner in which amounts made available to that agency for drug control are being used by that agency.
(2)Protection of intelligence information
(A)In general
The authorities conferred on the Office and the Director by this chapter shall be exercised in a manner consistent with provisions of the National Security Act of 1947 [50 U.S.C. 3001 et seq.]. The Director of National Intelligence shall prescribe such regulations as may be necessary to protect information provided pursuant to this chapter regarding intelligence sources and methods.
(B)Duties of Director
The Director of National Intelligence and the Director of the Central Intelligence Agency shall, to the maximum extent practicable in accordance with subparagraph (A), render full assistance and support to the Office and the Director.
(3)Required reports
(A)Secretaries of the Interior and Agriculture
Not later than July 1 of each year, the Secretaries of Agriculture and the Interior shall jointly submit to the Director and the appropriate congressional committees an assessment of the quantity of illegal drug cultivation and manufacturing in the United States on lands owned or under the jurisdiction of the Federal Government for the preceding year.
(B)Secretary of Homeland Security
Not later than July 1 of each year, the Secretary of Homeland Security shall submit to the Director and the appropriate congressional committees information for the preceding year regarding—
(i)the number and type of seizures of drugs by each component of the Department of Homeland Security seizing drugs, as well as statistical information on the geographic areas of such seizures; and
(ii)the number of air and maritime patrol hours primarily dedicated to drug supply reduction missions undertaken by each component of the Department of Homeland Security.
(C)Secretary of Defense
The Secretary of Defense shall, by July 1 of each year, submit to the Director and the appropriate congressional committees information for the preceding year regarding the number of air and maritime patrol hours primarily dedicated to drug supply reduction missions undertaken by each component of the Department of Defense.
(D)Attorney General
The Attorney General shall, by July 1 of each year, submit to the Director and the appropriate congressional committees information for the preceding year regarding the number and type of— (i)
(ii)prosecutions for drug violations by United States Attorneys; and
(iii)seizures of drugs by each component of the Department of Justice seizing drugs, as well as statistical information on the geographic areas of such seizures.
(b)Certification of policy changes to Director (c) General Services Administration
(1)In general
Subject to paragraph (2), the head of a National Drug Control Program agency shall, unless exigent circumstances require otherwise, notify the Director in writing regarding any proposed change in policies relating to the activities of that agency under the National Drug Control Program prior to implementation of such change. The Director shall promptly review such proposed change and certify to the head of that agency in writing whether such change is consistent with the National Drug Control Strategy.
(2)Exception
If prior notice of a proposed change under paragraph (1) is not practicable—
(A)the head of the National Drug Control Program agency shall notify the Director of the proposed change as soon as practicable; and
(B)upon such notification, the Director shall review the change and certify to the head of that agency in writing whether the change is consistent with the National Drug Control Strategy.
(d)Accounting of funds expended
(1)In general
Not later than February 1 of each year, in accordance with guidance issued by the Director, the head of each National Drug Control Program agency shall submit to the Director a detailed accounting of all funds expended by the agency for National Drug Control Program activities during the previous fiscal year and shall ensure such detailed accounting is authenticated for the previous fiscal year by the Inspector General for such agency prior to the submission to the Director as frequently as determined by the Inspector General but not less frequently than every 3 years.
(2)Submission to Congress
The Director shall submit to Congress not later than April 1 of each year the information submitted to the Director under paragraph (1).
(e)Drug court training and technical assistance program
(1)Grants authorized
The Director may make a grant to a nonprofit organization for the purpose of providing training and technical assistance to drug courts.
(2)Authorization of appropriations
There is authorized to be appropriated to carry out this subsection $2,000,000 for each of fiscal years 2018 through 2023.
(f)Tracking system for federally funded grant programs
(1)Establishment
The Director, or the head of an agency designated by the Director, in coordination with the Secretary of Health and Human Services, shall track federally-funded grant programs to—
(A)ensure the public has electronic access to information identifying:
(i)all drug control grants and pertinent identifying information for each grant; and
(ii)any available performance metrics, evaluations, or other information indicating the effectiveness of such programs;
(B)facilitate efforts to identify duplication, overlap, or gaps in funding to provide increased accountability of Federally-funded grants for substance use disorder treatment, prevention, and enforcement; and
(C)identify barriers that may impede applicants in the grant application process.
(2)National Drug Control Program Agencies
The head of each National Drug Control Program agency shall provide to the Director a complete list of all drug control program grant programs and any other relevant information for inclusion in the system developed under paragraph (1) and annually update such list.
(3)Updating existing systems
The Director may meet the requirements of this subsection by utilizing, updating, or improving existing Federal information systems to ensure they meet the requirements of this subsection.
(4)Report
Not later than 3 years after October 24, 2018, the Comptroller General of the United States shall submit to Congress a report examining implementation of this subsection.

Legislative History

Notes & Related Subsidiaries

Editorial Notes

References in Text

The National Security Act of 1947, referred to in subsec. (a)(2)(A), is act July 26, 1947, ch. 343, 61 Stat. 495, which was formerly classified principally to chapter 15 (§ 401 et seq.) of Title 50, War and National Defense, prior to editorial reclassification in Title 50, and is now classified principally to chapter 44 (§ 3001 et seq.) of Title 50. For complete classification of this Act to the Code, see Tables.

Amendments

2019—Pub. L. 116–74, § 2(a)(1), substituted “National Drug Control Program agency” for “National Drug Control Program Agency” wherever appearing. Subsec. (d)(1). Pub. L. 116–74, § 2(a)(6)(A), substituted “than every” for “that every”. Subsec. (f)(1)(A)(i). Pub. L. 116–74, § 2(a)(6)(B)(i)(I), substituted “grant; and” for “grant;”. Subsec. (f)(1)(C). Pub. L. 116–74, § 2(a)(6)(B)(i)(II), inserted “that may impede applicants” after “barriers” and struck out “impediments that applicants currently have in the grant application process with applicable agencies” before period at end. Subsec. (f)(2). Pub. L. 116–74, § 2(a)(6)(B)(ii), substituted “Drug Control Program” for “Drug Control” in heading. 2018—Pub. L. 115–271, § 8202(b)(2), repealed Pub. L. 105–277, § 715. See 1998 Amendment note below. Pub. L. 115–271, § 8202(a), revived and restored this section as in effect on Sept. 29, 2003, and as amended by Pub. L. 109–469 and Pub. L. 112–166. See Reauthorization of the Office of National Drug Control Policy note set out under section 1701 of this title. Subsec. (d). Pub. L. 115–271, § 8217(g)(1), amended subsec. (d) generally. Prior to amendment, text read as follows: “The Director shall— “(A) require the National Drug Control Program agencies to submit to the Director not later than February 1 of each year a detailed accounting of all funds expended by the agencies for National Drug Control Program activities during the previous fiscal year, and require such accounting to be authenticated by the Inspector General for each agency prior to submission to the Director; and “(B) submit to Congress not later than April 1 of each year the information submitted to the Director under subparagraph (A).” Subsec. (e). Pub. L. 115–271, § 8207, added subsec. (e). Subsec. (f). Pub. L. 115–271, § 8217(g)(2), added subsec. (f). 2006—Pub. L. 109–469, § 602, amended Pub. L. 105–277, § 715, which provided for the repeal of this section. See 1998 Amendment note below. Subsec. (a)(1)(A). Pub. L. 109–469, § 104(1), struck out “abuse” after “drug”. Subsec. (a)(2)(A). Pub. L. 109–469, § 104(2), substituted “Director of National Intelligence” for “Director of Central Intelligence”. Subsec. (a)(2)(B). Pub. L. 109–469, § 104(3), substituted “Director of National Intelligence and the Director of the Central Intelligence Agency” for “Director of Central Intelligence”. Subsec. (a)(3). Pub. L. 109–469, § 104(4), amended par. (3) generally. Prior to amendment, text read as follows: “The Secretary of Agriculture shall annually submit to the Director an assessment of the acreage of illegal drug cultivation in the United States.” Subsec. (b)(2)(B). Pub. L. 109–469, § 104(5), substituted “Strategy” for “Program”. Subsec. (c). Pub. L. 109–469, § 104(6), substituted “on” for “in”. 1998—Pub. L. 105–277, § 715, as amended by Pub. L. 109–469, § 602, which provided for the repeal of this section effective Sept. 30, 2010, was repealed by Pub. L. 115–271, § 8202(b)(2). See former section 1712 of this title.

Reference

Citations & Metadata

Citation

21 U.S.C. § 1704

Title 21, Food and Drugs

Last Updated

Sep 22, 2026

Release point: 119-110